Jeffrey Hubbell to Drug Delivery Systems
This is a "connection" page, showing publications Jeffrey Hubbell has written about Drug Delivery Systems.
Connection Strength
2.874
-
Prescription for a pharmacyte. Sci Transl Med. 2015 Jun 10; 7(291):291fs23.
Score: 0.456
-
Extracellular matrix-inspired growth factor delivery systems for bone regeneration. Adv Drug Deliv Rev. 2015 Nov 01; 94:41-52.
Score: 0.452
-
Drug development: longer-lived proteins. Chem Soc Rev. 2012 Apr 07; 41(7):2686-95.
Score: 0.362
-
Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004 Jul; 25(16):3245-57.
Score: 0.214
-
Protein delivery from materials formed by self-selective conjugate addition reactions. J Control Release. 2001 Sep 11; 76(1-2):11-25.
Score: 0.176
-
Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 2001 May; 15(7):1300-2.
Score: 0.172
-
Intraarterial protein delivery via intimally-adherent bilayer hydrogels. J Control Release. 2000 Feb 14; 64(1-3):205-15.
Score: 0.158
-
Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials. 1993 Oct; 14(13):1008-16.
Score: 0.101
-
Controlled release nanoparticle-embedded coatings reduce the tissue reaction to neuroprostheses. J Control Release. 2010 Aug 03; 145(3):196-202.
Score: 0.080
-
Materials engineering for immunomodulation. Nature. 2009 Nov 26; 462(7272):449-60.
Score: 0.078
-
Extracellular matrix binding mixed micelles for drug delivery applications. J Control Release. 2009 Jul 20; 137(2):146-51.
Score: 0.074
-
Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials. 2009 Mar; 30(9):1763-71.
Score: 0.073
-
PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules. 2007 Jun; 8(6):1966-72.
Score: 0.065
-
Controlled release drug coatings on flexible neural probes. Annu Int Conf IEEE Eng Med Biol Soc. 2007; 2007:6613-6.
Score: 0.064
-
Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci. 2006 Oct 01; 29(2):120-9.
Score: 0.061
-
Glucose-oxidase based self-destructing polymeric vesicles. Langmuir. 2004 Apr 27; 20(9):3487-91.
Score: 0.053
-
Immunoengineering approaches for cytokine therapy. Am J Physiol Cell Physiol. 2021 08 01; 321(2):C369-C383.
Score: 0.043
-
Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release. 2000 Apr 03; 65(3):389-402.
Score: 0.040
-
Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses. Biomaterials. 2017 07; 132:48-58.
Score: 0.032
-
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A. 2013 Dec 03; 110(49):19902-7.
Score: 0.026
-
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials. 2014 Jan; 35(2):814-24.
Score: 0.025
-
Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials. 2012 Sep; 33(26):6211-9.
Score: 0.023
-
Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater. 2008 Mar; 7(3):248-54.
Score: 0.017
-
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release. 2006 May 01; 112(1):26-34.
Score: 0.015
-
Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release. 2005 Jan 03; 101(1-3):93-109.
Score: 0.014